Nomad Power Solutions (NMAD) Enterprise Value (2010 - 2026)
Nomad Power Solutions (NMAD) posted Enterprise Value of $102.8 million for Q2 2026, up 452.47% on a QoQ basis from $18.6 million in Q4 2025, and up 6371.86% year-over-year from $1.6 million in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Enterprise Value (2010 - 2026) Analysis & Trends
Nomad Power Solutions has reported Enterprise Value for 17 years, with the latest figure at $102.8 million in Q2 2026.
- On a quarterly basis, Enterprise Value rose 6371.86% year-over-year to $102.8 million in Q2 2026; TTM through Jun 2026 was $102.8 million, a 6371.86% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 42.62% from the prior year.
- Enterprise Value was $102.8 million for Q2 2026 at Nomad Power Solutions, up from $18.6 million in the prior quarter.
- The five-year high for Enterprise Value was $165.3 million in Q1 2022, with the low at $405149.6 in Q3 2023.
- Average Enterprise Value over 5 years is $44.3 million, with a median of $6.9 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value sank 99.53% in 2023, then jumped 6371.86% in 2026.
- Over 5 years, Enterprise Value stood at $79.5 million in 2022, then tumbled by 98.64% to $1.1 million in 2023, then jumped by 225.88% to $3.5 million in 2024, then soared by 427.57% to $18.6 million in 2025, then jumped by 452.47% to $102.8 million in 2026.
- The last three Enterprise Value figures came in at $102.8 million (Q2 2026), $18.6 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.80 Mn |
| Dec 31, 2025 | 18.61 Mn |
| Sep 30, 2025 | 25.80 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 405,149.61 |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 134.18 Mn |
| Dec 31, 2022 | 79.54 Mn |
| Sep 30, 2022 | 86.66 Mn |
| Jun 30, 2022 | 115.45 Mn |
| Mar 31, 2022 | 165.31 Mn |
| Dec 31, 2021 | 158.76 Mn |
| Sep 30, 2021 | 279.97 Mn |
| Jun 30, 2021 | 407.20 Mn |